Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism (Q46881384)

26 December 2017

title

Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism (English)

1 reference

26 December 2017

0 references

Ying-Xin Fan

1

1 reference

26 December 2017

Lily Wong

2

1 reference

26 December 2017

Jinhui Ding

3

1 reference

26 December 2017

Nikolay A Spiridonov

4

1 reference

26 December 2017

Richard C Johnson

5

1 reference

26 December 2017

Gibbes R Johnson

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

26 November 2007

1 reference

26 December 2017

Journal of Biological Chemistry

published in

1 reference

26 December 2017

volume

283

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

1588-1596

1 reference

26 December 2017

Oncogenic kinase signalling

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

The conformational plasticity of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

EGF-ERBB signalling: towards the systems level

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Structure of the extracellular region of HER3 reveals an interdomain tether

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Insights into the HER-2 receptor tyrosine kinase mechanism and substrate specificity using a transient kinetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Comparison of the biochemical and kinetic properties of the type 1 receptor tyrosine kinase intracellular domains. Demonstration of differential sensitivity to kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

A quantitative protein interaction network for the ErbB receptors using protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Activation of chicken liver dihydrofolate reductase by urea and guanidine hydrochloride is accompanied by conformational change at the active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M708116200

21 January 2018

Identifiers

DOI

10.1074/JBC.M708116200

1 reference

26 December 2017

PubMed ID

18039657

1 reference

26 December 2017